Consensus CVRx, Inc.

Stocks

CVRX

US1266381052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 00:00:00 21/08/2026 +04			5-day change	1st Jan Change
2.840 ^USD	+0.71%		-3.40%	-60.00%

08-11	CVRx, Inc. Announces Executive Changes, Effective August 11, 2026	CI
08-07	Top Midday Decliners	MT

Evolution of the Average Target: CVRx, Inc.

Evolution of the Target Price: CVRx, Inc.

Changes in Analyst Recommendations: CVRx, Inc.

909544fbd9baa47ae85795050426e.PI8fW7jFPAvIp3UmG3_IkMZOisVCXftwadoSDjFU1pQ.WOcqE_aKfia890RkTzqj-IQE7YpwaZkgB5MkR3oWpf1momUI2fVjc6LmMA~163387a88d01a14a5fcab92d77680d47

Analysts' recommendations: CVRx, Inc.

08-07	Top Midday Decliners	MT
08-07	Piper Sandler Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $4 From $12	MT
09/05/25	JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15	MT
10/09/24	Cantor Fitzgerald Initiates CVRx at Overweight With $14 Price Target	MT
01/05/24	JPMorgan Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $13 From $36	MT
01/05/24	William Blair Downgrades CVRx to Market Perform From Outperform	MT
26/01/24	JPMorgan Raises CVRx's Price Target to $36 From $31, Keeps Overweight Rating	MT
22/01/24	Lake Street Adjusts CVRx Price Target to $35 From $32, Maintains Buy Rating	MT
27/12/23	Lake Street Raises CVRx Price Target to $32 From $21, Maintains Buy Rating	MT
27/11/23	Craig Hallum Adjusts CVRx Price Target to $24 From $22, Maintains Buy Rating	MT
03/05/23	Lake Street Adjusts CVRx's Price Target to $18 From $15, Keeps Buy Rating	MT
10/02/23	Piper Sandler Adjusts Price Target on CVRx to $20 From $18.50, Maintains Overweight Rating	MT
07/02/23	Canaccord Genuity Adjusts Price Target on CVRx to $23 From $22, Maintains Buy Rating	MT
27/01/23	JPMorgan Adjusts Price Target on CVRx to $18 From $17, Maintains Overweight Rating	MT
02/11/22	Piper Sandler Adjusts Price Target on CVRx to $14 From $10, Maintains Overweight Rating	MT
18/07/22	Craig Hallum Initiates CVRx at Buy With $15 Price Target	MT
26/07/21	CVRx : Canaccord Genuity Initiates CVRx at Buy Rating With $30 Price Target	MT
26/07/21	CVRx : JPMorgan Starts CVRx at Overweight with $24 Price Target	MT
26/07/21	CVRx : William Blair Initiates Coverage on CVRx With Outperform Rating	MT
26/07/21	CVRx : Piper Sandler Starts CVRx at Overweight With $26 Price Target	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CVRX, INC.			+62.53%
PENUMBRA, INC.			+10.71%
GETINGE AB			-2.54%
ASAHI INTECC CO., LTD.			+9.21%
MINIMED GROUP, INC.			+3.03%
APT MEDICAL INC.			+40.46%
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.			+49.82%
NOVOCURE LIMITED			+49.14%
NAKANISHI INC.			+10.57%
IMPLANTICA AG	-	-	+38.37%
Average			+27.13%
Weighted average by Cap.			+16.62%